This expanded and revised companion to Brenner & Rector’s The Kidney delivers a new bench to bedside review of the management of patients with end-stage renal disease. Leaders in the field present expert coverage on the physiologic principles and clinical applications of different methods of renal replacement therapy as well as the most recent guidelines from the National Kidney Foundation regarding dialysis. With 4 new section editors, new authors, 50% more content, this new edition constitutes a sweeping revision to this popular text. * Presents the expertise of distinguished researchers and clinicians in the fields of hemodialysis, peritoneal dialysis, critical care nephrology, and transplantation. * Provides comprehensive coverage of clinical management issues of chronic kidney disease and dialysis and transplantation. * Features illustrations, including diagnostic and treatment algorithms, line drawings, and photographs. * Includes a complete list of references in each chapter.

.

GET IT HERE

.

http://medicalbooksfree.com/chronic-kidney-disease-dialysis-and-transplantation-a-companion-to-brenner-and-rectors-the-kidney-expert-consult-2010-edition

 




List Price: $200.00 USD
New From: $55.00 In Stock
Used from: $36.93 In Stock

VN:F [1.9.20_1166]
Rating: 10.0/10 (1 vote cast)
VN:F [1.9.20_1166]
Rating: +1 (from 1 vote)
Chronic Kidney Disease, Dialysis, & Transplantation: A Companion to Brenner & Rector's The Kidney, 10.0 out of 10 based on 1 rating

Social Share Toolbar

3 Responses to “Chronic Kidney Disease, Dialysis, & Transplantation: A Companion to Brenner & Rector’s The Kidney”

  1. [...] more: Chronic Kidney Disease, Dialysis, & Transplantation: A Companion … By admin | category: medical books | tags: bedside-review, brenner, end-stage-renal, [...]

  2. [...] the rest here: Chronic Kidney Disease, Dialysis, & Transplantation: A Companion … By admin | category: chronic treatment, treatment | tags: both-the-prevention, [...]

  3. A recommendation has been made to increase the warning for Covidien’s Optimark and GE’s Omnisca—gadolinium-based contrast agents (DBCAs)— because of the potential for an increased risk of nephrogenic systemic fibrosis (NSF). This site has good information on this issue: http://www.gadolinium-mri.com/index.html

    VA:F [1.9.20_1166]
    Rating: 0.0/5 (0 votes cast)
    VA:F [1.9.20_1166]
    Rating: 0 (from 0 votes)

Leave a Reply

(required)

(required)

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Why ask?

© 2013 MEDICAL BOOKS FREE Suffusion theme by Sayontan Sinha